Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	1uk2	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	GLY B 109 LEU B 202 PHE B 294 PHE B 8	1.30A	20.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	VAL A 933 ASP F 932 SER D1156 ASN F 937 VAL F1157	1.73A	14.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	1wnc	E2 GLYCOPROTEIN (SARSr)	5 / 12	ASP F 932 VAL F 933 SER D1156 VAL B 945 ASN B 942	1.20A	14.66	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	LEU H 133 VAL H 135 TRP H 159 ASN H 105 ASN H 110	1.69A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	VAL F 172 TRP F 187 ASP F 139 ASN F 114 VAL F 191	1.68A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2amd	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 153 PHE A 294 PHE A 8 PHE A 305 ASN A 151	1.64A	21.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.58A	21.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.60A	21.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.57A	21.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	VAL E 271 TRP E 302 PHE E 308 ASN E 355 TYR E 299	1.64A	14.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	2dd8	IGG HEAVY CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARSr-CoV)	5 / 12	VAL S 389 THR S 487 VAL H 97 ASN S 427 ASN S 424	1.15A	20.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	2dd8	IGG HEAVY CHAIN (Homo sapiens)	5 / 12	THR H 160 VAL H 163 SER H 180 ASN H 197 TYR H 194	1.55A	21.25	None None None PO4 H 501 (-3.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_2 (BETA-1 ADRENERGIC RECEPTOR)	2dd8	IGG HEAVY CHAIN (Homo sapiens)	4 / 4	VAL H 20 PHE H 29 VAL H 102 TRP H 103	1.71A	21.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	2ghv	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 6	VAL E 382 PHE E 364 PHE E 329 PHE E 325	1.30A	20.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2ghw	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	LEU A 503 VAL A 498 SER A 386 PHE A 329 TYR A 352	1.73A	16.88	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_2 (BETA-1 ADRENERGIC RECEPTOR)	2k87	NSP3 OF REPLICASE POLYPROTEIN 1A (SARSr-CoV)	3 / 3	VAL A 52 ASN A 101 TRP A 87	1.26A	16.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	4 / 6	LEU B 263 VAL B 275 PHE B 240 PHE B 329	1.31A	22.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	2qc2	3C-LIKE PROTEINASE (-)	5 / 12	THR B 304 VAL B 303 SER A 121 SER A 123 ASN A 28	1.75A	20.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2qcy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU A 75 VAL A 91 SER A 10 PHE A 159 PHE A 150	1.67A	20.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	VAL B 101 SER A 288 ASN B 163 VAL B 84 ASN B 62	1.31A	21.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2xyq	NSP10 PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	VAL B 42 ASP A 130 SER A 175 ASN A 43 TYR A 47	1.63A	17.23	None SAH A1293 (-3.7A) None SAH A1293 (-3.8A) SAH A1293 (-4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2xyq	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	VAL A 78 ASP A 130 SER A 201 ASN A 43 TYR A 47	1.76A	25.00	None SAH A1293 (-3.7A) None SAH A1293 (-3.8A) SAH A1293 (-4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2xyr	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	VAL A 78 ASP A 130 SER A 201 ASN A 43 TYR A 47	1.76A	24.93	None SFG A1298 (-3.6A) None SFG A1298 (-3.5A) SFG A1298 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2xyv	NSP10 PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	VAL B 42 ASP A 130 SER A 175 ASN A 43 TYR A 47	1.72A	17.57	None SAH A1300 (-3.7A) None SAH A1300 (-3.3A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	2z9l	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.51A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	3bgf	F26G19 FAB (Mus musculus)	5 / 12	VAL C 133 SER C 176 SER B 180 ASN C 137 VAL B 138	1.77A	20.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.27A	18.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.26A	18.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.27A	18.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	VAL A 404 ASP A 350 SER A 44 SER A 40 TYR A 385	1.70A	19.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3ea7	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.57A	20.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3ea7	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.59A	20.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3ea7	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.61A	20.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3i6k	BETA-2-MICROGLOBULIN HLA, A-2 MEMBRANE GLYCOPROTEIN PEPTIDE (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL A 12 PHE B 56 PHE B 62 TYR A 116	1.66A	3.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3i6k	BETA-2-MICROGLOBULIN HLA, A-2 MEMBRANE GLYCOPROTEIN PEPTIDE (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL A 12 PHE B 56 PHE B 62 TYR A 116	1.66A	3.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3i6k	BETA-2-MICROGLOBULIN HLA, A-2 MEMBRANE GLYCOPROTEIN PEPTIDE (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL A 12 PHE B 56 PHE B 62 TYR A 116	1.64A	3.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.62A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU B 141 VAL B 125 SER A 113 SER A 10 PHE A 305	1.64A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU A 75 VAL A 91 SER A 10 PHE A 159 PHE A 150	1.68A	21.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3scj	ACE2 (Homo sapiens)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.31A	19.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3scj	ACE2 (Homo sapiens)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.31A	19.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3scj	ACE2 (Homo sapiens)	5 / 12	LEU A 248 VAL A 244 ASP A 269 SER A 502 PHE A 452	1.30A	19.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.28A	19.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.27A	19.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.27A	19.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	3scl	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	VAL B 404 ASP B 350 SER B 43 SER B 40 TYR B 385	1.60A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	3to2	MD3-C9 PEPTIDE DERIVED FROM MEMBRANE GLYCOPROTEIN MHC CLASS I ANTIGEN (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL C 5 VAL A 25 PHE A 33 TYR A 99	1.62A	3.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3to2	BETA-2-MICROGLOBULIN MD3-C9 PEPTIDE DERIVED FROM MEMBRANE GLYCOPROTEIN MHC CLASS I ANTIGEN (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL A 12 SER B 33 PHE B 56 TYR A 116	1.56A	3.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3to2	BETA-2-MICROGLOBULIN MD3-C9 PEPTIDE DERIVED FROM MEMBRANE GLYCOPROTEIN MHC CLASS I ANTIGEN (Homo sapiens; SARS-COV TJF)	5 / 12	LEU C 6 VAL A 12 SER B 33 PHE B 56 TYR A 116	1.61A	3.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3vb3	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU A 141 VAL A 125 SER B 113 SER B 10 PHE B 305	1.53A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	3vb3	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	LEU A 141 VAL A 125 SER B 113 SER B 10 PHE B 305	1.54A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	VAL A 255 PHE A 292 ASN A 114 VAL A 268 ASN A 267	1.46A	22.07	PO4 A 404 (-3.9A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5c8s	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	5 / 12	VAL D 182 VAL D 66 SER C 33 ASN D 63 ASN D 71	1.70A	20.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	VAL D 162 VAL D 125 ASN D 137 VAL D 120 TRP D 159	1.62A	20.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	VAL B 389 THR B 403 VAL B 405 SER B 407 PHE B 506	1.66A	20.52	SAM B 605 ( 4.8A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	5c8u	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	VAL D 162 VAL D 125 ASN D 137 VAL D 120 TRP D 159	1.50A	20.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5f22	NSP8 (SARSr-CoV)	5 / 12	LEU B 133 VAL B 135 TRP B 159 ASN B 105 ASN B 110	1.71A	19.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	VAL B 162 VAL B 125 ASN B 137 VAL B 120 TRP B 159	1.58A	20.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	VAL D 389 THR D 403 VAL D 405 SER D 407 PHE D 506	1.64A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	5 / 12	LEU A 27 VAL A 20 ASP A 187 VAL A 186 ASN A 180	1.80A	19.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.76A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.76A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5wrg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	LEU A 735 VAL A 958 SER C 556 PHE A 837 ASN A 838	1.67A	13.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 64 SER A 35 PHE A 262 PHE A 62 TYR A 41	1.63A	24.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 64 SER A 35 PHE A 262 PHE A 62 TYR A 41	1.60A	24.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 64 SER A 35 PHE A 262 PHE A 62 TYR A 41	1.64A	24.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	4 / 6	GLY C1026 PHE C1034 PHE C 909 PHE C 782	1.09A	13.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	LEU B 944 VAL B 945 SER A 582 PHE A 305 ASN A 304	1.54A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	LEU B 944 VAL B 945 SER A 582 PHE A 305 ASN A 304	1.45A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	PHE C 185 PHE C 168 ASN C 118 VAL C 97 ASN C 96	1.79A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	LEU B 944 VAL B 945 SER A 582 PHE A 305 ASN A 304	1.55A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	VAL A 518 THR B 259 SER A 439 SER A 440 ASN A 475	1.67A	13.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	VAL C 307 THR C 302 VAL C 583 ASN C 281 TYR C 598	1.51A	13.34	VAL C 307 ( 0.6A) THR C 302 ( 0.8A) VAL C 583 ( 0.6A) ASN C 281 ( 0.6A) TYR C 598 ( 1.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 6	GLY B1026 PHE B1034 PHE B 909 PHE B 782	1.10A	12.13	GLY B1026 ( 0.0A) PHE B1034 ( 1.3A) PHE B 909 ( 1.3A) PHE B 782 ( 1.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	VAL A 808 PHE A 815 ASN A 942 VAL A 934 ASN A 935	1.47A	13.34	VAL A 808 ( 0.6A) PHE A 815 ( 1.3A) ASN A 942 ( 0.6A) VAL A 934 ( 0.6A) ASN A 935 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	VAL C 307 THR C 302 VAL C 583 ASN C 281 TYR C 598	1.50A	13.34	VAL C 307 ( 0.6A) THR C 302 ( 0.8A) VAL C 583 ( 0.6A) ASN C 281 ( 0.6A) TYR C 598 ( 1.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	5zvm	PAN-COV INHIBITORY PEPTIDE EK1 SPIKE GLYCOPROTEIN (SARSr-CoV; synthetic construct)	5 / 12	VAL a 13 PHE c 15 ASN C 935 VAL A 934 ASN A 937	1.67A	11.30	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6acc	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 64 SER A 35 PHE A 262 PHE A 62 TYR A 41	1.48A	13.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	PHE B 185 PHE B 168 ASN B 118 VAL B 97 ASN B 96	1.64A	13.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	LEU B 538 VAL B 537 THR B 559 SER A 956 SER A 957	1.26A	13.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	LEU B 538 VAL B 537 THR B 559 SER A 956 SER A 957	1.29A	13.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASP B 376 SER A 728 ASN B 526 VAL B 314 ASN B 528	1.52A	12.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 6	GLY C 928 LEU C 927 PHE C1044 PHE C1024	1.00A	12.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASP C 727 PHE B 578 PHE C 837 PHE B 558 VAL B 537	1.75A	12.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 6	GLY C1026 PHE C1034 PHE C 909 PHE C 782	1.28A	13.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	PHE C 76 PHE C 22 ASN C 135 ASN C 78 TYR C 252	1.69A	12.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6cs0	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 6	GLY C1026 PHE C1034 PHE C 909 PHE C 782	1.10A	12.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6cs1	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	VAL A 496 VAL A 510 SER A 380 VAL A 498 TYR A 352	1.71A	12.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6cs2	ACE2 (Homo sapiens)	5 / 12	LEU D 248 VAL D 244 ASP D 269 SER D 502 PHE D 452	1.36A	19.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 64 SER B 35 PHE B 262 PHE B 62 TYR B 41	1.42A	12.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	VAL C 307 THR C 302 VAL C 583 ASN C 281 TYR C 598	1.32A	12.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	VAL C 307 THR C 302 VAL C 583 ASN C 281 TYR C 598	1.33A	12.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6jyt	HELICASE (SARSr-CoV)	5 / 12	LEU A 41 ASP A 56 VAL B 45 SER B 13 PHE B 24	1.62A	18.95	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6jyt	HELICASE (SARSr-CoV)	5 / 12	LEU A 41 ASP A 56 VAL B 45 SER B 13 PHE B 24	1.63A	18.95	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	VAL C 324 THR C 313 VAL C 50 SER C 227 SER C 430	1.56A	19.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	4 / 6	GLY C 82 LEU C 85 PHE C 283 PHE C 48	1.05A	19.15	None None LEU C 707 (-3.8A) LEU C 707 (-4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_2 (BETA-1 ADRENERGIC RECEPTOR)	6m17	ACE2 RECEPTOR BINDING DOMAIN (Homo sapiens; SARS-CoV-2)	3 / 3	VAL F 445 ASN D 49 TRP D 48	1.49A	20.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m1d	ACE2 SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	4 / 6	GLY B 747 LEU B 743 VAL A 207 PHE A 425	1.29A	15.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 VAL A 20 ASP A 187 VAL A 186 ASN A 180	1.77A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.70A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.74A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 VAL A 20 ASP A 187 VAL A 186 ASN A 180	1.77A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 VAL A 20 ASP A 187 VAL A 186 ASN A 180	1.78A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 141 VAL A 125 SER C 113 SER C 10 PHE C 305	1.63A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.72A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	LEU A 141 VAL A 125 SER C 113 SER C 10 PHE C 305	1.64A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m3m	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	LEU D 122 TRP D 133 VAL D 73 SER D 79 PHE D 54	1.66A	19.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m3m	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	LEU D 122 TRP D 133 VAL D 73 SER D 79 PHE D 54	1.63A	19.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m3m	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	LEU D 122 TRP D 133 VAL D 73 SER D 79 PHE D 54	1.63A	19.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.66A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.54A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.00A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.66A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.68A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.49A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.35A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	0.99A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.63A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.53A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.64A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.37A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.39A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	VAL A 354 ASP A 358 SER A 367 VAL A 535 ASN A 534	1.72A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 351 VAL A 299 SER A 561 ASN A 568 ASN A 657	1.54A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	4 / 6	LEU A 282 VAL A 353 PHE A 275 PHE A 326	1.68A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.27A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.39A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.74A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.27A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6m71	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.40A	15.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 6	GLY B1026 PHE B1034 PHE B 909 PHE B 782	1.22A	13.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6nb8	S230 ANTIGEN-BINDING (FAB) FRAGMENT, HEAVY CHAIN S230 ANTIGEN-BINDING (FAB) FRAGMENT, LIGHT CHAIN (Homo sapiens)	5 / 12	VAL H 221 THR H 179 VAL H 195 SER L 181 VAL H 135	1.63A	21.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6nur	NSP12 (SARSr-CoV)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.35A	14.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6nur	NSP12 (SARSr)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	0.90A	14.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6nur	NSP12 (SARSr-CoV)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.38A	14.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6nur	NSP12 (SARSr-CoV)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.37A	14.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6nur	NSP12 (SARSr-CoV)	5 / 12	VAL A 354 ASP A 358 SER A 367 VAL A 535 ASN A 534	1.72A	14.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6nus	NSP12 (SARSr-CoV)	5 / 12	VAL A 398 THR A 538 ASP A 377 VAL A 373 ASN A 356	1.69A	14.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY B1044 PHE B1052 PHE B 927 PHE B 800	1.15A	13.84	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	ASP C 614 VAL C 615 SER C 591 PHE C 592 ASN C 317	1.53A	14.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	ASP C 614 VAL C 615 SER C 591 PHE C 592 ASN C 317	1.53A	14.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	ASP C 614 VAL C 615 SER C 591 PHE C 592 ASN C 317	1.51A	14.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vw1	ACE2 (Homo sapiens)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.27A	18.73	None None None CL B 704 ( 4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vw1	ACE2 (Homo sapiens)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.27A	18.73	None None None CL B 704 ( 4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vw1	ACE2 (Homo sapiens)	5 / 12	LEU B 248 VAL B 244 ASP B 269 SER B 502 PHE B 452	1.26A	18.73	None None None CL B 704 ( 4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vww	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	5 / 12	LEU B 73 VAL B 70 ASP B 125 VAL B 128 ASN B 63	1.51A	23.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxs	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxs	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 121 PHE B 6	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxs	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxs	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxs	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxx	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.60A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxx	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.62A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxx	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY B 700 LEU B 699 VAL B 705 PHE C 888	1.24A	13.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vxx	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.60A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.56A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.56A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER C 60 SER C 31 PHE C 275 PHE C 58 TYR C 37	1.59A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	VAL A 320 SER B 982 ASN A 542 VAL A 539 ASN A 540	1.56A	13.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY B1044 PHE B1052 PHE B 927 PHE B 800	1.19A	13.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w01	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY A 130 LEU A 134 PHE A 123 PHE A 177	1.31A	21.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	GLY C 431 VAL C 341 PHE C 374 PHE C 347	1.44A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	4 / 6	GLY H 139 LEU H 124 VAL H 207 PHE H 122	1.54A	21.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	LEU C 461 VAL C 433 PHE C 464 PHE C 429	1.79A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	GLY C 431 VAL C 341 PHE C 374 PHE C 347	1.45A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	4 / 6	GLY H 139 LEU H 124 VAL H 207 PHE H 122	1.55A	21.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	GLY C 381 VAL C 511 PHE C 377 PHE C 374	1.63A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	GLY C 381 VAL C 511 PHE C 377 PHE C 374	1.63A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 6	LEU C 461 VAL C 433 PHE C 464 PHE C 429	1.79A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w4h	NSP16 (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.69A	23.34	None SAM A7102 (-3.7A) ACT A7103 (-2.6A) SAM A7102 (-3.6A) SAM A7102 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w4h	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.52A	16.72	None None ACT A7103 (-2.6A) None SAM A7102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w4h	NSP16 (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.38A	22.67	None SAM A7102 (-3.7A) ACT A7103 (-2.6A) SAM A7102 (-3.6A) SAM A7102 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w4h	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.62A	16.83	None SAM A7102 (-3.7A) ACT A7104 ( 4.8A) SAM A7102 (-3.6A) SAM A7102 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.63A		SAM A7104 (-3.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.63A		None SAM A7104 (-3.8A) EDO A7102 ( 4.7A) SAM A7104 (-3.3A) SAM A7104 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.63A		SAM A7104 (-3.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.70A		None SAM A7104 (-3.8A) None SAM A7104 (-3.3A) SAM A7104 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.56A		None None None None SAM A7104 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w61	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.53A		None None None None SAM A7104 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w63	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.68A		X77 A 401 (-3.6A) X77 A 401 ( 3.9A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w63	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.68A		X77 A 401 (-3.6A) X77 A 401 ( 3.9A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 121 PHE A 6	1.75A	18.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 121 PHE B 6	1.72A	18.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 121 PHE A 6	1.75A	18.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w6y	NSP3 (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 121 PHE B 6	1.72A	18.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4310 ASP C6906 VAL A7094 ASN C6862 ASN A7096	1.74A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.46A	16.72	None None FMT C7108 ( 2.7A) None SAM C7105 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A	18.57	SAM A7102 ( 3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4310 ASP C6906 VAL A7094 ASN C6862 ASN A7096	1.71A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.68A	18.73	None SAM A7102 ( 3.7A) FMT A7104 ( 2.9A) SAM A7102 ( 3.4A) SAM A7102 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.76A	16.72	None None FMT C7108 ( 3.4A) None SAM C7105 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.77A	16.72	None None FMT C7108 ( 3.4A) None SAM C7105 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.62A	16.83	None SAM A7102 ( 3.7A) None SAM A7102 ( 3.4A) SAM A7102 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.49A	16.72	None None FMT C7108 ( 2.7A) None SAM C7105 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	5 / 12	VAL C6876 ASP C6928 SER C6999 ASN C6841 TYR C6845	1.67A	18.73	None SAM C7105 ( 3.7A) FMT C7108 ( 2.7A) SAM C7105 ( 3.7A) SAM C7105 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.60A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.51A	16.72	None None FMT A7104 ( 2.9A) None SAM A7102 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.61A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.56A	18.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A	18.57	SAM A7102 ( 3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.78A	16.72	None None FMT A7104 ( 3.3A) None SAM A7102 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 ASP C6928 SER C6973 ASN C6841 TYR C6845	1.62A	16.83	None SAM C7105 ( 3.7A) None SAM C7105 ( 3.7A) SAM C7105 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.57A	18.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.60A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.63A	18.57	SAM C7105 ( 3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.48A	16.72	None None FMT A7104 ( 2.9A) None SAM A7102 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.61A	16.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP16 (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.64A	18.57	SAM C7105 ( 3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6w75	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.79A	16.72	None None FMT A7104 ( 3.3A) None SAM A7102 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6w9q	3C-LIKE PROTEINASE PEPTIDE, NSP9 FUSION (SARS-CoV-2)	4 / 6	GLY A 104 LEU A 103 VAL A 7 PHE A -4	1.49A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6w9q	3C-LIKE PROTEINASE PEPTIDE, NSP9 FUSION (SARS-CoV-2)	4 / 6	GLY A 104 LEU A 103 VAL A 7 PHE A -4	1.49A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wcf	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wcf	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 121 PHE A 6	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wcf	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wcf	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 121 PHE A 6	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wen	NSP3 (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wey	NSP3 (SARS-CoV-2)	5 / 12	ASP A 218 ASN A 321 VAL A 325 ASN A 354 TYR A 221	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wey	NSP3 (SARS-CoV-2)	4 / 6	GLY A 289 LEU A 292 VAL A 299 PHE A 320	1.59A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wey	NSP3 (SARS-CoV-2)	4 / 6	GLY A 289 LEU A 292 VAL A 299 PHE A 320	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	VAL C 270 TRP C 301 PHE C 307 ASN C 354 TYR C 298	1.76A		None CL C 401 ( 4.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 6	GLY B 287 LEU B 291 VAL B 350 PHE B 307	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 6	GLY F 287 LEU F 291 VAL F 350 PHE F 307	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 6	GLY F 287 LEU F 291 VAL F 350 PHE F 307	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	VAL A 270 TRP A 301 PHE A 307 ASN A 354 TYR A 298	1.77A		None CL A 401 ( 4.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL C6876 ASP C6928 SER C6999 ASN C6841 TYR C6845	1.64A		None SAH C7102 (-3.7A) None SAH C7102 (-3.7A) SAH C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.78A		None None None None SAH C7102 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.78A		None None None None SAH A7102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.65A		SAH C7102 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.51A		None None FMT A7104 (-3.1A) None SAH A7102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.58A	23.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.61A		None SAH A7102 (-3.7A) None SAH A7102 (-3.6A) SAH A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.48A		None None None None SAH C7102 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.59A	23.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.77A		None None None None SAH A7102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.48A		None None FMT A7104 (-3.1A) None SAH A7102 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A		SAH A7102 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL D4295 ASP C6928 SER C6973 ASN C6841 TYR C6845	1.61A		None SAH C7102 (-3.7A) None SAH C7102 (-3.7A) SAH C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.65A		None SAH A7102 (-3.7A) FMT A7104 (-3.1A) SAH A7102 (-3.6A) SAH A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.77A		None None None None SAH C7102 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL C6876 ASP C6928 SER C6999 ASN C6841 TYR C6845	1.79A		None SAH C7102 (-3.7A) None SAH C7102 (-3.7A) SAH C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A		SAH A7102 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.65A		SAH C7102 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.51A		None None None None SAH C7102 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.78A		None SAH A7102 (-3.7A) FMT A7104 (-3.1A) SAH A7102 (-3.6A) SAH A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkp	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 6	GLY B 137 LEU B 139 PHE B 110 PHE B 53	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkp	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 6	GLY B 137 LEU B 139 PHE B 110 PHE B 53	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.61A	23.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.78A		None None None None FMT C7112 ( 3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.52A		None None FMT A7106 ( 3.2A) None FMT A7104 ( 3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.64A		SFG C7103 ( 3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.47A		None None FMT C7110 ( 3.1A) None FMT C7112 ( 3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.60A		None SFG A7103 ( 3.6A) None FMT A7104 ( 3.1A) SFG A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 ASP C6928 SER C6973 ASN C6841 TYR C6845	1.61A		None SFG C7103 ( 3.7A) None FMT C7112 ( 3.3A) SFG C7103 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 SER C6999 VAL C6842 ASN C6841	1.50A		None None FMT C7110 ( 3.1A) None FMT C7112 ( 3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4310 ASP C6906 VAL A7094 ASN C6862 ASN A7096	1.79A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY D4347 LEU D4345 VAL C6842 PHE D4321	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A		SFG A7103 ( 3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4295 SER C6998 ASN C6996 VAL C6842 ASN C6841	1.76A		None None None None FMT C7112 ( 3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL D4310 ASP C6906 VAL A7094 ASN C6862 ASN A7096	1.77A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	5 / 12	VAL C6876 ASP C6928 SER C6999 ASN C6841 TYR C6845	1.65A		None SFG C7103 ( 3.7A) FMT C7110 ( 3.1A) FMT C7112 ( 3.3A) SFG C7103 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	5 / 12	LEU C6857 VAL C6859 THR C6854 SER C7041 PHE C7048	1.60A	23.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.66A		SFG A7103 ( 3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.77A		None None None None FMT A7104 ( 3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.79A		None SFG A7103 ( 3.6A) FMT A7106 ( 3.2A) FMT A7104 ( 3.1A) SFG A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.66A		None SFG A7103 ( 3.6A) FMT A7106 ( 3.2A) FMT A7104 ( 3.1A) SFG A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.49A		None None FMT A7106 ( 3.2A) None FMT A7104 ( 3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.78A		None None None None FMT A7104 ( 3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP16 (SARS-CoV-2)	4 / 6	GLY C6879 LEU C6883 VAL C6995 PHE C6991	1.64A		SFG C7103 ( 3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wkq	NSP10 NSP16 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY B 230 VAL B 237 PHE B 222 PHE B 214	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY B 130 LEU B 134 PHE B 123 PHE B 177	1.32A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY B 230 VAL B 237 PHE B 222 PHE B 214	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY A 130 LEU A 134 PHE A 123 PHE A 177	1.33A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY B 130 LEU B 134 PHE B 123 PHE B 177	1.32A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	5 / 12	LEU A 73 VAL A 70 ASP A 125 VAL A 128 ASN A 63	1.51A		None EDO A 408 (-4.0A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY A 230 VAL A 237 PHE A 222 PHE A 214	1.65A		SO4 A 410 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY A 130 LEU A 134 PHE A 123 PHE A 177	1.32A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	5 / 12	LEU B 73 VAL B 70 ASP B 125 VAL B 128 ASN B 63	1.48A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wlc	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARS-CoV-2)	4 / 6	GLY A 230 VAL A 237 PHE A 222 PHE A 214	1.65A		SO4 A 410 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 121 PHE B 6	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 121 PHE B 6	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 ASN A6996 VAL A6842 ASN A6841	1.79A		None None GTA A7102 (-3.9A) None SO4 A7109 ( 3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.69A		None SAH A7101 (-3.7A) GTA A7102 (-2.5A) SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.39A		None SAH A7101 (-3.7A) GTA A7102 (-2.5A) SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 SER A6999 ASN A6841 TYR A6845	1.42A		None SAH A7101 (-3.7A) GTA A7102 (-2.5A) SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.60A		SAH A7101 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.57A		None None GTA A7102 (-2.5A) None SO4 A7109 ( 3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 SER A6998 SER A6999 VAL A6842 ASN A6841	1.54A		None None GTA A7102 (-2.5A) None SO4 A7109 ( 3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 ASN A6996 ASN A6841 TYR A6845	1.69A		None SAH A7101 (-3.7A) GTA A7102 (-3.9A) SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	5 / 12	VAL B4295 ASP A6928 SER A6973 ASN A6841 TYR A6845	1.61A		None SAH A7101 (-3.7A) None SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE NSP10 (SARS-CoV-2)	4 / 6	GLY B4347 LEU B4345 VAL A6842 PHE B4321	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 12	VAL A6876 ASP A6928 ASN A6996 ASN A6841 TYR A6845	1.70A		None SAH A7101 (-3.7A) GTA A7102 (-3.9A) SO4 A7109 ( 3.2A) SAH A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 6	GLY A6879 LEU A6883 VAL A6995 PHE A6991	1.60A		SAH A7101 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wqd	NSP8 (SARS-CoV-2)	5 / 12	VAL D 167 TRP D 182 ASP D 134 ASN D 109 VAL D 186	1.79A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wqd	NSP8 (SARS-CoV-2)	5 / 12	LEU D 128 VAL D 130 TRP D 154 ASN D 100 ASN D 105	1.79A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wqd	NSP8 (SARS-CoV-2)	5 / 12	LEU B 128 VAL B 130 TRP B 154 ASN B 100 ASN B 105	1.73A		None None None None EDO B 301 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wrh	PEPTIDASE C16 (SARS-CoV-2)	5 / 12	LEU A 101 THR A 115 VAL A 165 SER A 245 PHE A 173	1.73A	21.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6wrh	PEPTIDASE C16 (SARS-CoV-2)	5 / 12	LEU A 101 THR A 115 VAL A 165 SER A 245 PHE A 173	1.74A	21.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.76A	19.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 6	GLY A 143 LEU A 27 VAL A 114 PHE A 112	1.76A	19.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	5 / 12	LEU B 128 VAL B 130 TRP B 154 ASN B 100 ASN B 105	1.78A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	5 / 12	LEU D 128 VAL D 130 TRP D 154 ASN D 100 ASN D 105	1.77A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yi3	NUCLEOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 97 LEU A 99 PHE A 70 PHE A 13	1.58A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yi3	NUCLEOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 97 LEU A 99 PHE A 70 PHE A 13	1.58A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 431 VAL A 341 PHE A 374 PHE A 347	1.47A		None None DMS A 901 (-4.3A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.70A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.46A		None None DMS E 901 (-4.4A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	4 / 6	GLY B 143 LEU B 128 VAL B 211 PHE B 126	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	THR B 139 SER C 120 ASN C 144 VAL B 167 TRP B 158	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 431 VAL A 341 PHE A 374 PHE A 347	1.45A		None None DMS A 901 (-4.3A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL B 211 THR B 169 VAL B 185 SER C 182 VAL B 125	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	THR H 139 SER L 120 ASN L 144 VAL H 167 TRP H 158	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL B 211 THR B 169 VAL B 185 SER C 182 VAL B 125	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	THR B 164 VAL B 167 SER B 184 ASN B 201 ASN B 159	1.58A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.47A		None None DMS E 901 (-4.4A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	THR B 164 VAL B 167 SER B 184 ASN B 201 ASN B 159	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	VAL H 125 TRP H 158 VAL H 188 SER H 190 SER H 192	1.79A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN (Homo sapiens)	4 / 6	GLY B 143 LEU B 128 VAL B 211 PHE B 126	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	THR B 139 SER C 120 ASN C 144 VAL B 167 TRP B 158	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	THR H 139 SER L 120 ASN L 144 VAL H 167 TRP H 158	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	4 / 6	GLY H 143 LEU H 128 VAL H 211 PHE H 126	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.47A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	4 / 6	GLY H 143 LEU H 128 VAL H 211 PHE H 126	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	VAL H 125 TRP H 158 VAL H 188 SER H 190 SER H 192	1.78A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.46A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	VAL H 125 TRP H 158 VAL H 188 SER H 190 SER H 192	1.76A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.70A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	THR B 139 SER C 120 ASN C 144 VAL B 167 TRP B 158	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	VAL B 211 THR B 169 VAL B 185 SER C 182 VAL B 125	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	THR H 139 SER L 120 ASN L 144 VAL H 167 TRP H 158	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 431 VAL A 341 PHE A 374 PHE A 347	1.46A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	VAL B 211 THR B 169 VAL B 185 SER C 182 VAL B 125	1.70A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	VAL H 211 THR H 169 VAL H 185 SER L 182 VAL H 125	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.47A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	VAL B 125 TRP B 158 VAL B 188 SER B 190 SER B 192	1.80A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY E 431 VAL E 341 PHE E 374 PHE E 347	1.46A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	THR B 164 VAL B 167 SER B 184 ASN B 201 ASN B 159	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	THR B 164 VAL B 167 SER B 184 ASN B 201 ASN B 159	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	THR H 139 SER L 120 ASN L 144 VAL H 167 TRP H 158	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 12	THR B 139 SER C 120 ASN C 144 VAL B 167 TRP B 158	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	VAL H 125 TRP H 158 VAL H 188 SER H 190 SER H 192	1.79A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	THR H 164 VAL H 167 SER H 184 ASN H 201 ASN H 159	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 6	GLY A 431 VAL A 341 PHE A 374 PHE A 347	1.47A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6yt8	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.77A	22.01	PK8 A 401 ( 3.6A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	6yt8	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.74A	22.01	PK8 A 401 ( 3.6A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	6yt8	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	LEU A 27 ASP A 187 VAL A 186 ASN A 180 TYR A 54	1.78A		PK8 A 401 ( 3.6A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.59A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY E 85 LEU E 88 VAL E 95 PHE E 116	1.59A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY E 85 LEU E 88 VAL E 95 PHE E 116	1.58A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 51 LEU D 53 VAL C 63 PHE D 156	1.18A		None None None EDO D 209 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 51 LEU D 53 VAL C 63 PHE D 156	1.18A		None None None EDO D 209 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY E 85 LEU E 88 VAL E 95 PHE E 116	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY E 85 LEU E 88 VAL E 95 PHE E 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 51 LEU D 53 VAL C 63 PHE D 156	1.14A		None None None EDO D 204 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 85 LEU D 88 VAL D 95 PHE D 116	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY D 51 LEU D 53 VAL C 63 PHE D 156	1.14A		None None None EDO D 204 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY A 85 LEU A 88 VAL A 95 PHE A 116	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY B 85 LEU B 88 VAL B 95 PHE B 116	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 6	GLY C 85 LEU C 88 VAL C 95 PHE C 116	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 127 VAL A 128 VAL A 190 PHE A 287 TYR A 237	1.53A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.40A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.38A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	VAL A 472 VAL A 128 VAL A 704 ASN A 705 TYR A 788	1.49A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 127 VAL A 128 VAL A 190 PHE A 287 TYR A 237	1.54A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP8 (SARS-CoV-2)	5 / 12	LEU D 128 VAL D 130 TRP D 154 ASN D 100 ASN D 105	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 352 LEU A 351 PHE A 313 PHE A 317	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 841 LEU A 838 PHE A 881 PHE A 920	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.38A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.71A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 351 VAL A 299 SER A 561 ASN A 568 ASN A 657	1.45A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.70A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.20A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.41A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.37A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.36A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.66A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	VAL A 299 ASP A 358 SER A 363 VAL A 535 ASN A 534	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.19A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 663 VAL A 662 VAL A 299 ASN A 356 ASN A 657	1.77A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 401 THR A 540 VAL A 560 SER A 564 PHE A 506	1.79A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 841 LEU A 838 PHE A 881 PHE A 920	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	LEU A 127 VAL A 128 VAL A 190 PHE A 287 TYR A 237	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.38A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	5 / 12	VAL A 472 VAL A 128 VAL A 704 ASN A 705 TYR A 788	1.49A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7btf	NSP12 (SARS-CoV-2)	4 / 6	GLY A 352 LEU A 351 PHE A 313 PHE A 317	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.61A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	VAL A 880 PHE A 419 PHE A 429 PHE A 428	1.67A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.42A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	LEU A 329 VAL B 115 ASP A 377 VAL A 373 ASN A 360	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.41A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	VAL A 299 ASP A 358 SER A 363 VAL A 535 ASN A 534	1.76A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.62A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.17A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	LEU A 351 VAL A 299 SER A 561 ASN A 568 ASN A 657	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.35A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.37A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	LEU A 282 VAL A 353 PHE A 275 PHE A 326	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.71A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	THR A 538 ASP A 377 VAL A 373 ASN A 356 VAL A 330	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	VAL A 880 PHE A 419 PHE A 429 PHE A 428	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	VAL A 472 VAL A 128 VAL A 704 ASN A 705 TYR A 788	1.58A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	LEU A 316 VAL A 353 PHE A 321 PHE A 326	1.62A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	LEU A 329 VAL B 115 ASP A 377 VAL A 373 ASN A 360	1.61A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP8 (SARS-CoV-2)	5 / 12	LEU A 329 VAL B 115 ASP A 377 VAL A 373 ASN A 360	1.56A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	LEU A 282 VAL A 353 PHE A 275 PHE A 326	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	THR A 538 ASP A 377 VAL A 373 ASN A 356 VAL A 330	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.42A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv1	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.16A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	VAL A 880 PHE A 419 PHE A 429 PHE A 428	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 352 LEU A 351 PHE A 313 PHE A 317	1.59A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	VAL A 880 PHE A 419 PHE A 429 PHE A 428	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.77A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.70A	15.77	None None None None U T 8 ( 3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.38A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.23A	15.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	VAL A 398 THR A 394 ASN A 459 VAL A 675 TYR A 453	1.77A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.39A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.50A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 678 LEU A 663 VAL A 792 PHE A 694	1.25A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.41A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 388 VAL A 398 THR A 402 PHE A 504 ASN A 507	1.64A	15.77	None None None None U T 8 ( 3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 351 VAL A 299 SER A 561 ASN A 568 ASN A 657	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU C 40 VAL A 435 PHE A 429 PHE A 428	1.38A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.38A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 774 LEU A 707 PHE A 753 PHE A 782	1.65A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	4 / 6	GLY A 352 LEU A 351 PHE A 313 PHE A 317	1.60A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y01_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	LEU A 673 VAL A 398 ASP A 377 VAL A 373 ASN A 657	1.39A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_A_Y00A601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y00_B_Y00B601_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP8 (SARS-CoV-2)	5 / 12	ASP A 390 VAL B 131 PHE A 407 ASN A 447 TYR A 674	1.41A	15.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_1 (BETA-1 ADRENERGIC RECEPTOR)	7bv2	NSP12 NSP7 (SARS-CoV-2)	4 / 6	LEU A 544 VAL C 11 PHE A 442 PHE A 843	1.51A		None